Las Vegas, NV -- (SBWIRE) -- 10/25/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Delcath Systems, Inc.(NASDAQ:DCTH), Cenveo, Inc. (NYSE:CVO), A.P. Pharma, Inc. (OTCBB: APPA), China Sunergy Co Ltd (NASDAQ:CSUN)
Delcath Systems, Inc.(NASDAQ:DCTH) managed to keep its gain at 2.52% on below -normal volume of 3.72M shares. The stock settled at $0.325 after floating in a range of $0.31 to $0.33. Its latest price has reached market capitalization of $33.01 million. Its 52-week range has been $0.29 to $2.19. Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers in the liver. Delcath focuses on the development and clinical study of the Delcath chemosaturation system.
For How Long DCTH will fight for Profitability? Read This Trend Analysis report
Cenveo, Inc. (NYSE:CVO) traded up on a volume of 3.56 million, higher than its standard daily volume. Shares have gained 5.37% to $3.14. Over the last twelve months, the stock has gained 46.05% and faced a worst price of $1.85. Cenveo, Inc. is a diversified printing company in North America. The Company’s portfolio of products includes commercial printing, envelope converting, label manufacturing and specialty packaging production. It operates a network of manufacturing facilities, serving a diverse base of over 100,000 customers.
For How Long CVO’s Gloss will Attract Investors? Find out via this report
A.P. Pharma, Inc. (OTCBB: APPA) settled 8.88% higher at $0.460 on above-normal volume of 3.88M shares during the last trading day. The stock has its 12-month high at $0.89 and 52-week low price was $0.28. It traded in a range of $0.42 to $0.46 during the last trading day. A.P. Pharma, Inc. (A.P. Pharma) is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform.
Why Should Investors Buy APPA After the Recent Fall? Just Go Here and Find Out
In the last trading session, China Sunergy Co Ltd (NASDAQ:CSUN) was up on high volume, trading at a volume of 3.15M shares versus its average daily volume of 3.15 million shares. At $7.82, the stock has attained market capitalization of $116.12 million. China Sunergy Co., Ltd. (China Sunergy) manufactures and sells solar cell and solar module products that convert sunlight into electricity for a variety of uses.
Will CSUN Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)